Frailty and sarcopenia: definitions and outcome parameters

[1]  S. Kritchevsky,et al.  Leg Muscle Mass and Composition in Relation to Lower Extremity Performance in Men and Women Aged 70 to 79: The Health, Aging and Body Composition Study , 2002, Journal of the American Geriatrics Society.

[2]  J. Kaufman,et al.  Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. , 1996, The Journal of clinical endocrinology and metabolism.

[3]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  B. Nicklas,et al.  Exercise Training as a Treatment for Chronic Inflammation in the Elderly , 2009, Exercise and sport sciences reviews.

[5]  E. Barrett-Connor,et al.  Sarcopenia in elderly men and women: the Rancho Bernardo study. , 2003, American journal of preventive medicine.

[6]  M. Inzitari,et al.  Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force , 2009, The journal of nutrition, health & aging.

[7]  D. Kiel,et al.  Effect of Dietary Protein on Bone Loss in Elderly Men and Women: The Framingham Osteoporosis Study , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  M. Schroll,et al.  Muscle Strength After Resistance Training Is Inversely Correlated with Baseline Levels of Soluble Tumor Necrosis Factor Receptors in the Oldest Old , 2004, Journal of the American Geriatrics Society.

[9]  J. Kaufman,et al.  Androgens in male senescence , 1998 .

[10]  W. Frontera,et al.  Strength conditioning in older men: skeletal muscle hypertrophy and improved function. , 1988, Journal of applied physiology.

[11]  S. Rubin,et al.  Type and Intensity of Activity and Risk of Mobility Limitation: The Mediating Role of Muscle Parameters , 2005, Journal of the American Geriatrics Society.

[12]  Michael E. Miller,et al.  Designing clinical trials of interventions for mobility disability: results from the lifestyle interventions and independence for elders pilot (LIFE-P) trial. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[13]  C. Cooper,et al.  The developmental origins of sarcopenia , 2008, The journal of nutrition, health & aging.

[14]  S. Studenski,et al.  Gait speed and survival in older adults. , 2011, JAMA.

[15]  P. Mcneil,et al.  Role of muscle-derived growth factors in bone formation. , 2010, Journal of musculoskeletal & neuronal interactions.

[16]  E. Nieschlag,et al.  Testosterone: Action, Deficiency, Substitution , 1990 .

[17]  Y. Rolland,et al.  Clinical trials on sarcopenia: methodological issues regarding phase 3 trials. , 2011, Clinics in geriatric medicine.

[18]  J. Baeyens,et al.  European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .

[19]  S. Roth,et al.  Myostatin: a therapeutic target for skeletal muscle wasting , 2004, Current opinion in clinical nutrition and metabolic care.

[20]  M. Cesari,et al.  Designing phase II B trials in sarcopenia: The best target population , 2011, The journal of nutrition, health & aging.

[21]  R. Ch.,et al.  NUTRITION IN GERIATRICS. , 1963 .

[22]  A. Mitnitski,et al.  Frailty in relation to the accumulation of deficits. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[23]  T. Jørgensen,et al.  Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. , 2007, The Journal of clinical endocrinology and metabolism.

[24]  G. Paolisso,et al.  Frailty and muscle metabolism dysregulation in the elderly , 2010, Biogerontology.

[25]  Avan Aihie Sayer,et al.  Is grip strength associated with health-related quality of life? Findings from the Hertfordshire Cohort Study. , 2006, Age and ageing.

[26]  L. Ferrucci,et al.  International working group on Sarcopenia , 2011 .

[27]  S. Studenski.  What are the outcomes of treatment among patients with sarcopenia? , 2009, The journal of nutrition, health & aging.

[28]  G. Biolo,et al.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". , 2010, Clinical nutrition.

[29]  R. Gougeon,et al.  Protein turnover and requirements in the healthy and frail elderly. , 2006, The journal of nutrition, health & aging.

[30]  Sundeep Khosla,et al.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. , 2008, Endocrine reviews.

[31]  R B Wallace,et al.  Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. , 1995, The New England journal of medicine.

[32]  J. Morley,et al.  Growth Hormone: Fountain of Youth or Death Hormone? , 1999, Journal of the American Geriatrics Society.

[33]  S. Bhasin,et al.  The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[34]  P. Cawthon,et al.  Sarcopenia: etiology, clinical consequences, intervention, and assessment , 2009, Osteoporosis International.

[35]  Butler Rn.  Did you say 'sarcopenia'? , 1993 .

[36]  R. Butler.  Did you say 'sarcopenia'? , 1993, Geriatrics.

[37]  C. Cooper,et al.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women , 2008, Osteoporosis International.

[38]  R. Baumgartner,et al.  Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. , 2004, Obesity research.

[39]  D. Kuh,et al.  Objectively measured physical capability levels and mortality , 2010 .

[40]  W. O'Fallon,et al.  Epidemiology of Sarcopenia , 2000, Journal of the American Geriatrics Society.

[41]  Robert Ross,et al.  Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability , 2002, Journal of the American Geriatrics Society.

[42]  L. Fried,et al.  Association of IGF-I levels with muscle strength and mobility in older women. , 2001, The Journal of clinical endocrinology and metabolism.

[43]  T. Manini,et al.  Sarcopenia: Clinical evaluation, biological markers and other evaluation tools , 2009, The journal of nutrition, health & aging.

[44]  W. Evans.  What is sarcopenia? , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[45]  J. E. Morley,et al.  Sarcopenia: Diagnosis and treatment , 2008, The journal of nutrition, health & aging.

[46]  J. Kaufman,et al.  The decline of androgen levels in elderly men and its clinical and therapeutic implications. , 2005, Endocrine reviews.

[47]  C. Cooper,et al.  Does admission grip strength predict length of stay in hospitalised older patients? , 2006, Age and ageing.

[48]  C. Löwik,et al.  A new paradigm in the treatment of osteoporosis: Wnt pathway proteins and their antagonists. , 2007, Current opinion in investigational drugs.

[49]  E. Masoro.  Aging: current concepts. , 2011 .

[50]  J. Kaufman,et al.  Testosterone: Androgens in male senescence , 2004 .

[51]  A. Rossi,et al.  Sarcopenic obesity: a new category of obesity in the elderly. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[52]  C. Cooper,et al.  Does sarcopenia originate in early life? Findings from the Hertfordshire cohort study. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[53]  J. Morley,et al.  Endocrinology in aging. , 1988, Disease-a-month : DM.

[54]  M. Fiatarone,et al.  Effects of High-Intensity Strength Training on Multiple Risk Factors for Osteoporotic Fractures: A Randomized Controlled Trial , 1994 .

[55]  E. Lewiecki,et al.  Treatment of osteoporosis with denosumab. , 2010, Maturitas.

[56]  Kevin Flurkey,et al.  Handbook of physiology, section 11: Aging by E.J. Masoro (Ed.), Oxford University Press, Oxford, 1995. ISBN 0-19-507722-9, $165.00, 681 pp , 1996, Experimental Gerontology.

[57]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[58]  C. Wolfson,et al.  Frailty and its association with disability and comorbidity in a community-dwelling sample of seniors in Montreal: a cross-sectional study , 2010 .

[59]  L. Ferrucci,et al.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[60]  C. Cooper,et al.  Do All Systems Age Together? , 1999, Gerontology.

[61]  C. Cooper,et al.  Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? , 2005, Diabetes care.

[62]  C. Cooper,et al.  Prevalence and correlates of frailty among community-dwelling older men and women: findings from the Hertfordshire Cohort Study. , 2010, Age and ageing.

[63]  J. Rowe,et al.  Human aging: usual and successful. , 1987, Science.

[64]  M J Evanich,et al.  Some limitations on the removal of periodic noise by averaging. , 1972, Journal of applied physiology.

[65]  I. Janssen,et al.  Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study. , 2009, The American journal of clinical nutrition.

[66]  C. Jankowski.  The Lifestyle Interventions and Independence for Elders Pilot (LIFE-P): 2-Year Follow-up , 2010 .

[67]  S. Kandarian,et al.  Intracellular signaling during skeletal muscle atrophy , 2006, Muscle & nerve.

[68]  A. Vermeulen.  Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels. , 1987, The Journal of clinical endocrinology and metabolism.

[69]  L. Melton,et al.  Epidemiology of sarcopenia. , 2000, Journal of the American Geriatrics Society.

[70]  W. Evans,et al.  Sarcopenia and age-related changes in body composition and functional capacity. , 1993, The Journal of nutrition.

[71]  S. Heymsfield,et al.  Epidemiology of sarcopenia among the elderly in New Mexico. , 1998, American journal of epidemiology.

[72]  R. Wolfe.  The underappreciated role of muscle in health and disease. , 2006, The American journal of clinical nutrition.

[73]  L. Ferrucci,et al.  Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. , 2003, The Journal of clinical endocrinology and metabolism.

[74]  D. Cameron-Smith,et al.  Aging and its effects on inflammation in skeletal muscle at rest and following exercise-induced muscle injury. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[75]  G. A. Kan.  Epidemiology and consequences of sarcopenia. , 2009 .

[76]  R. Baumgartner.  Body Composition in Healthy Aging , 2000, Annals of the New York Academy of Sciences.

[77]  W. Evans.  Drug discovery and development for ageing: opportunities and challenges , 2011, Philosophical Transactions of the Royal Society B: Biological Sciences.

[78]  J. Guralnik,et al.  Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women , 2004, International Journal of Obesity.

[79]  L. Lipsitz,et al.  High-intensity strength training in nonagenarians. Effects on skeletal muscle. , 1990, JAMA.

[80]  S. Studenski,et al.  Meaningful Change and Responsiveness in Common Physical Performance Measures in Older Adults , 2006, Journal of the American Geriatrics Society.

[81]  R. Kreisberg,et al.  Measurement of muscle mass in humans by isotopic dilution of creatine-14C. , 1970, Journal of applied physiology.

[82]  R. J. Shephard,et al.  Objectively measured physical capability levels and mortality: systematic review and meta-analysis , 2011 .

[83]  A. H. Norris,et al.  Longitudinal changes in basal metabolism in man. , 1978, Journal of applied physiology: respiratory, environmental and exercise physiology.

[84]  J. Bauer,et al.  Sarcopenia and frailty: A clinician’s controversial point of view , 2008, Experimental Gerontology.

[85]  Sandrine Andrieu,et al.  Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. , 2011, Journal of the American Medical Directors Association.

[86]  S. Studenski,et al.  Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. , 2006, JAMA.

[87]  S B Roberts,et al.  Exercise training and nutritional supplementation for physical frailty in very elderly people. , 1994, The New England journal of medicine.